What Is Vitamin K Deficiency Bleeding
Vitamin K deficiency bleeding (VKDB), formerly known as hemorrhagic disease of the newborn, is a condition caused by low levels of vitamin K-dependent clotting factors. VKDB can occur early, classic, or late in infancy and in individuals with malabsorption or certain medication use. Because vitamin K is essential for activating clotting factors II, VII, IX, and X, deficiency impairs coagulation and can lead to serious bleeding. This evergreen explainer covers incidence, risk factors, prevention, and treatment based on current clinical guidance.
How Vitamin K Deficiency Bleeding Occurs
Role of Vitamin K in Clotting
Vitamin K functions as a cofactor for the gamma-carboxylation of specific glutamic acid residues in clotting factors II (prothrombin), VII, IX, and X, as well as proteins C and S. Without adequate carboxylation, these factors cannot bind calcium and participate effectively in the coagulation cascade. Insufficient vitamin K results in reduced functional clotting factors, raising the risk of spontaneous or procedural bleeding.
Forms and Mechanisms of VKDB
- Early-onset VKDB: Within 24 hours of birth, often linked to maternal medications that interfere with vitamin K transfer or fetal activation.
- Classic VKDB: Days 2–7 of life, corresponding to physiological nadir in vitamin K stores and low intake.
- Late-onset VKDB: 2 weeks to 6 months, associated with chronic malabsorption and low vitamin K intake.
In adults, VKDB is less common and usually tied to malabsorption syndromes, prolonged antibiotic use, or drugs that antagonize vitamin K.
Epidemiology and Incidence Trends
Reported incidence varies by region, prophylaxis policies, and case definitions. Studies and surveillance programs provide the following benchmarks, noting that regional practices affect absolute numbers.
Incidence by Age Group and Prophylaxis Status
| Metric | Estimate or Range | Source Type |
|---|---|---|
| Early-onset VKDB incidence (with no prophylaxis) | 0.25% to 2% of newborns | Observational studies |
| Classic VKDB incidence (with routine prophylaxis) | Less than 0.1% of newborns | Surveillance data |
| Late-onset VKDB incidence | Approximately 1 to 4 per 100,000 live births annually | Public health registries |
| Increased risk with exclusive breastfeeding and no prophylaxis | Higher relative risk compared with formula feeding | Epidemiological reviews |
Risk Factors and Variability
- Low placental transfer of vitamin K.
- Inadequate vitamin K intake during pregnancy and lactation.
- Chronic diarrhea, cholestatic liver disease, or cystic fibrosis.
- Use of anticoagulants or certain antibiotics.
- Lack of vitamin K prophylaxis at birth.
Prevention Strategies and Public Health Measures
Routine vitamin K prophylaxis at birth has markedly reduced the incidence of late-onset VKDB. Approaches include:
- Intramuscular vitamin K injection shortly after birth.
- Oral vitamin K regimens where injectable vitamin K is not preferred, with attention to adherence and completeness of dosing.
- Maternal education on signs of bleeding and when to seek care.
- For at-risk infants, coordination with pediatric hematology and ongoing monitoring of vitamin K status.
Diagnosis and Laboratory Assessment
Diagnosis integrates clinical findings with laboratory evaluation. Key points include:
- Prolonged prothrombin time (PT) and elevated international normalized ratio (INR) are common indicators.
- Measurement of vitamin K-dependent clotting factors can confirm functional deficiency.
- Imaging and additional hemostatic testing may be needed to localize bleeding and exclude other causes.
Treatment and Management Principles
Acute management focuses on controlling bleeding and correcting coagulopathy:
- Administration of vitamin K, typically via slow intravenous, intramuscular, or oral routes depending on severity.
- Use of fresh frozen plasma or prothrombin complex concentrate for urgent reversal in life-threatening bleeding.
- Supportive care, including monitoring of vital signs, laboratory parameters, and addressing underlying causes.
Long-Term Outlook and Follow-Up
With appropriate treatment, outcomes are generally favorable. However, prevention remains critical, especially for late-onset cases. Recommendations include:
- Ensuring vitamin K prophylaxis at birth per local guidelines.
- For individuals with malabsorption, periodic assessment and tailored supplementation under medical supervision.
- Education for caregivers about signs of bleeding and adherence to prescribed regimens.
Key Takeaways
- Vitamin K deficiency bleeding stems from impaired activation of clotting factors II, VII, IX, and X.
- Incidence is low where vitamin K prophylaxis is routine, but can rise in populations with limited access or in infants who are exclusively breastfed without supplementation.
- Early recognition, appropriate use of vitamin K replacement, and supportive care lead to favorable outcomes.